These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 18763590)

  • 1. [Vaccine prophylaxis of viral hepatitis B in patients with acute leukemia].
    Gurina NM; Svedentsov EP; Shardakov VI; Cherepanova VV
    Ter Arkh; 2008; 80(7):27-9. PubMed ID: 18763590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The assessment of efficacy of hepatitis B prophylaxis in children with acute lymphoblastic leukemia].
    Moryl-Bujakowska A; Czogała M; Czogała W; Balwierz W
    Przegl Lek; 2004; 61 Suppl 2():85-8. PubMed ID: 15686054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy of two dosages of recombinant hepatitis B vaccine in healthy adolescents in India.
    Velu V; Nandakumar S; Shanmugam S; Shankar EM; Thangavel S; Kulkarni PS; Thyagarajan SP
    Pediatr Infect Dis J; 2007 Nov; 26(11):1038-41. PubMed ID: 17984812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of vaccination against hepatitis B in adult with HIV infection].
    Kalinowska-Nowak A; Bociaga-Jasik M; Garlicki A; Mach T
    Przegl Epidemiol; 2007; 61(2):339-47. PubMed ID: 17956052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-year vaccination against hepatitis B virus with a MPL-vaccine in liver transplant patients for HBV-related cirrhosis.
    Di Paolo D; Lenci I; Cerocchi C; Tariciotti L; Monaco A; Brega A; Lotti L; Tisone G; Angelico M
    Transpl Int; 2010 Nov; 23(11):1105-12. PubMed ID: 20492620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
    Betancourt AA; Delgado CA; Estévez ZC; Martínez JC; Ríos GV; Aureoles-Roselló SR; Zaldívar RA; Guzmán MA; Baile NF; Reyes PA; Ruano LO; Fernández AC; Lobaina-Matos Y; Fernández AD; Madrazo AI; Martínez MI; Baños ML; Alvarez NP; Baldo MD; Mestre RE; Pérez MV; Martínez ME; Escobar DA; Guanche MJ; Cáceres LM; Betancourt RS; Rando EH; Nieto GE; González VL; Rubido JC
    Int J Infect Dis; 2007 Sep; 11(5):394-401. PubMed ID: 17257877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
    Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults.
    Bailey CL; Smith V; Sands M
    Int J Infect Dis; 2008 Nov; 12(6):e77-83. PubMed ID: 18723381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose intradermal and subcutaneous versus intramuscular hepatitis B vaccination in primary non-responding hemodialysis patients.
    Sorkhi H; Dooki MR; Ebrahimnejad MS
    J Med Assoc Thai; 2006 Oct; 89(10):1648-53. PubMed ID: 17128839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpected protection from infection by two booster hepatitis B virus vaccination in children with acute lymphoblastic leukemia.
    Yetgin S; Tavil B; Aytac S; Kuskonmaz B; Kanra G
    Leuk Res; 2007 Apr; 31(4):493-6. PubMed ID: 16930691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation on efficacy of plasma-derived hepatitis B vaccine and persistence of protective level after vaccination].
    Wang S; Wu C; Li Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Jun; 15(3):154-7. PubMed ID: 7834691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy of hepatitis B vaccination in healthcare workers of Oil Company Hospital, Tehran, Iran (1989-2005).
    Alavian SM; Mansouri S; Abouzari M; Assari S; Bonab MS; Miri SM
    Eur J Gastroenterol Hepatol; 2008 Feb; 20(2):131-4. PubMed ID: 18188034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Humoral immunity level and factors associated with the response to the vaccine against the hepatitis B virus in health personnel of the Case-Essalud National Hospital, Arequipa September 1995-March 2002].
    Campos Nizama J
    Rev Gastroenterol Peru; 2005; 25(2):141-9. PubMed ID: 16021199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of intradermal hepatitis B vaccination compared to intramuscular vaccination in hemodialysis patients.
    Chanchairujira T; Chantaphakul N; Thanwandee T; Ong-Ajyooth L
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S33-40. PubMed ID: 17044452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term efficacy of plasma-derived and recombinant hepatitis B vaccines in a rural township of Central Taiwan.
    Kao JT; Wang JH; Hung CH; Yen YH; Hung SF; Hu TH; Lee CM; Lu SN
    Vaccine; 2009 Mar; 27(12):1858-62. PubMed ID: 19186203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of primary hepatitis B immunization in children with acute lymphoblastic leukemia.
    Baytan B; Gunes AM; Gunay U
    Indian Pediatr; 2008 Apr; 45(4):265-70. PubMed ID: 18451443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evaluation of the effectiveness of multiple dose intradermal hepatitis B re-vaccination in hemodialyzed patients not responding to standard method of immunization.
    Radziszewski A; Gajda M; Pituch-Noworolska A; Drozdz M; Kraśniak A; Kaczmarczyk I; Hołyś S; Zurowski J; Sydor A; Sułowicz W
    Przegl Lek; 2007; 64(7-8):470-5. PubMed ID: 18409347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus vaccine in lymphoproliferative disorders: a prospective randomized study evaluating the efficacy of granulocyte-macrophage colony stimulating factor as a vaccine adjuvant.
    Yağci M; Acar K; Sucak GT; Yamaç K; Haznedar R
    Eur J Haematol; 2007 Oct; 79(4):292-6. PubMed ID: 17655695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.